Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Studying Environmental Factors That May Raise Type 1 Diabetes Risk

Observes environmental causes of type 1 diabetes in people aged 3 to 70 in China.

Plain-language title generated from the registry record
Registry title: Environmental Determinants of Type 1 Diabetes Risk

Key facts

Where
Changsha, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 3 and 70 years old?

Source: NCT07835724, who can take part

Where in China

  • the Second Xiangya Hospital, central south of universityChangsha, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Second Xiangya Hospital of Central South University
Trial code
NCT07835724
Record updated
23 September 2026
Original description
To analyze the environmental risk factors for type 1 diabetes in China.Read full original descriptionShow less

Environmental Determinants of Type 1 Diabetes Risk

To analyze the environmental risk factors for type 1 diabetes in China.

Inclusion: Individuals with type 1 diabetes (no age restriction):; Clinically diagnosed with T1D by a specialist; Meeting any one of the following conditions:(1) Age of onset < 15 years;(2) No overweight or obesity at onset;(3) History of ketoacidosis; Insulin-dependent since disease onset; Positive for at least one islet autoantibody (GADA, IA-2A, ZnT8A, IAA, ICA); Disease duration ≤ 3 years; First-degree relatives:; Parents, siblings, or children of an individual with T1D; Age ≤ 45 years.

Exclusion: Current systemic immunosuppressive therapy; Current systemic glucocorticoid therapy; Participation in another drug or medical device trial during recruitment or the study period; Individuals with type 1 diabetes; Gestational diabetes; Confirmed monogenic diabetes; Secondary diabetes; Type 2 diabetes; Other specific types of diabetes; Severe active disease or a condition likely to substantially affect life expectancy, including malignancy or severe cardiac, pulmonary, hepatic, or renal disease; A condition that may require immunosuppressive therapy during the study period; History of major surgery or severe trauma; First-degree relatives:; Diagnosed with diabetes before screening; Previous or current use of glucose-lowering drugs; Common exclusion criteria:.

ClinicalTrials.gov NCT07835724